A recent systematic review observed that CRP levels were inconsistently associated with cognitive impairment in patients with psychosis [163], similarly, a meta-analysis that included studies of patients with psychotic and mood disorders found limited evidence to suggest that immune markers were associated with cognitive performance in the combined patient analysis or when stratified by diagnostic subgroup [219]. This evidence concerns the gene CRP and psychotic disorder.